A poster presented at the American Society of Nephrology's (ASN) Kidney Week 2019 sought to understand more about patient knowledge of anemia and its impact on patient quality of life, their understanding of the disease, as well as how their anemia is managed.
Of the 30 million patients in the United States with chronic kidney disease (CKD), about 5 million have anemia. A poster presented at the American Society of Nephrology's (ASN) Kidney Week 2019 sought to understand more about patient knowledge of anemia and its impact on patient quality of life, their understanding of the disease, as well as how their anemia is managed.
A quantitative online survey was administered to 500 patients in the United States aged 18 and older between August and September 2018 with self-reported CKD, with or without anemia. They were recruited via online communities and support groups, patient associations, and patient referrals. Data were aggregated and anonymized to protect confidentiality.
Respondents were 69% female, with a mean age of 52.2 years; the majority (68%) said they had moderate to severe CKD (stages 3—5); 24% had CKD stage 1 or 2; the remainder did not know their stage.
Of the entire cohort (n = 255), 57% reported being told they had anemia by a healthcare professional. Of the total, 66% ( n= 168) knew about the relationship between anemia and CKD. Of the entire group, 38% (n = 170) knew their hemoglobin levels; most were aware of the key symptoms linked with anemia, such as fatigue or weakness.
As for reported symptoms, patients with anemia reported lack of energy (82%), feeling sad and/or depressed (53%), noting pain (52%), difficulty sleeping (53%), and worrying about worsening anemia (63%).
Most patients (67%) stated that their anemia was well-managed with iron supplements (55%) or erythropoiesis-stimulating agents (30%); 11% had received transfusions. Less than half felt confident that they knew the adverse effects of their treatment.
Half of the patients reported they knew about different treatment options for anemia, and they most frequently used online sources, including social media, to learn about anemia. However, patients most trusted information that came from their provider, they reported.
The patients perceived that anemia had a negative impact on their physical symptoms and emotional wellbeing, and their knowledge and understanding of CKD anemia and its management varied, the researchers reported. The researchers, funded by AstraZeneca, said the findings demonstrate the challenges providers and patients have concerning the need for further education on the association between CKD and anemia, symptoms associated with anemia, and the available treatment options for anemia.
Reference
Palaka E, Guzman NJ, Dunn A, Wittbrodt ET, Grandy S, Finkelstein FO. Understanding patient perspectives of the impact, awareness, and treatment of CKD anemia: A US patient survey. Presented at: American Society of Nephrology Kidney Week 2019, Washington, DC; November 5-10, 2019. Poster 232.
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Dupilumab Considered Safe, Effective Treatment for Adolescent, Adult Patients With AD
March 20th 2024These posters both used the GLOBOSTAD study, which demonstrated through patient and physician assessments that dupilumab is a safe and effective treatment for adolescent and adult patients with atopic dermatitis (AD).
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Racial Variations in Cardiovascular Outcomes Found in Hidradenitis Suppurativa Study
March 19th 2024Based on the findings, investigators acknowledged the critical need to consider racial differences when assessing patients with hidradenitis suppurativa. Health care providers should be vigilant in addressing cardiovascular risk factors in this population, recognizing and addressing racial disparities that may impact disease management.
Read More